Home Logon FTA Investment Managers Blog Subscribe About Us Contact Us

Search by Ticker, Keyword or CUSIP       
 
 

Blog Home
   Brian Wesbury
Chief Economist
 
Bio
X •  LinkedIn
   Bob Stein
Deputy Chief Economist
Bio
X •  LinkedIn
 
  The Healthcare Dichotomy
Posted Under: CPI • Inflation • Productivity • Research Reports

The issue of runaway healthcare costs has been at the forefront of American politics for over a decade. We have all heard horror stories from the insured and uninsured alike: $1000 visits to the emergency room, $3000 MRIs, even trips to the pediatrician can give us sticker shock these days. To make matters worse, the accelerating retirement of the baby boomers promises to continue, if not exacerbate, this trend.

So what, if anything, can be done to arrest this rise in costs?

Surprisingly, answers may lie somewhere in the world of elective surgery. In 2014, roughly 11.3 million Americans chose to undergo either cosmetic or LASIK eye correction surgery. We chose to focus on these two categories of medical care because they are the most common types of elective procedures.  Uniquely, the costs associated with both have grown at a much more reasonable pace than medical care, and in the case of LASIK have actually fallen over the past two decades.

Using publically available data from The American Society for Aesthetic Plastic Surgery we created a price basket of the 10 most popular procedures and tracked it going back to 1998 when the data began being recorded. The result was a 33% increase in prices versus an 80% rise in the cost of medical care as reported by the Bureau of Labor Statistics over the same time period. Data from Allaboutvision.com, which has tracked the cost of LASIK since its approval by the FDA, shows an even more impressive drop in costs of 4% since 1998. In fact, looking at the table below you can see that elective procedures have risen less than not only medical care but general prices as well. It is also important to note that cost data for both types of elective procedures are in nominal terms, meaning they are both even lower when adjusted for inflation. On top of this, they offer satisfaction rates in the 90% range as opposed to roughly 70% for common surgeries in hospitals.


 
Supporting Image for Blog Post

 

So, why have we seen such a dichotomy between elective procedures and the rest of the healthcare industry? The answer lies in price discovery. Neither LASIK, nor cosmetic surgery are covered by insurance plans, Medicare, or Medicaid which means that patients are required to pay their medical expenses out of pocket. These are some of the few procedures that are sold in a free market, allowing for price advertising, consumer driven purchases, and competition. This gives the average person a much bigger incentive to shop around and find the best price and quality before making a decision.

This is in stark contrast to healthcare in the rest of the US where prices are opaque due to insurance, and rising constantly due to ever increasing built in administrative costs. In fact, the Wall Street Journal recently reported that some hospitals and medical centers are charging less for cash upfront than for copays on certain procedures in order to avoid the red tape from insurance and other collection hassles.

Don't get us wrong, we know it isn't feasible for patients to begin paying upfront in the majority of cases, and we aren't likening life threating illnesses to the less serious issues elective procedures solve. However, the more we obscure prices with new laws and further regulations the less incentive entrepreneurial doctors and surgeons have to innovate and produce the productivity gains we need to get prices under control. With the legal and administrative side of medicine ballooning like it has been, there's no wonder we have a shortage of medical students. Maybe they're all just becoming lawyers instead. 

Bryce Gill - Economic Analyst

Click here for PDF version

Posted on Friday, March 4, 2016 @ 2:05 PM • Post Link Print this post Printer Friendly

These posts were prepared by First Trust Advisors L.P., and reflect the current opinion of the authors. They are based upon sources and data believed to be accurate and reliable. Opinions and forward looking statements expressed are subject to change without notice. This information does not constitute a solicitation or an offer to buy or sell any security.
Search Posts
 PREVIOUS POSTS
Nonfarm Payrolls Increased 242,000 in February
The Trade Deficit in Goods and Services Came in at $45.7 Billion in January
Why "The Big Short" is a Big Lie
Nonfarm Productivity Declined at a 2.2% Annual Rate in the Fourth Quarter
The ISM Non-Manufacturing Index Declined to 53.4 in February
The ISM Manufacturing Index Rose to 49.5 in February
Currency Mayhem
M2 and C&I Loan Growth
Personal Income and Consumption Rise 0.5% in January
Real GDP Growth Revised Up to a 1% Annual Rate for Q4
Archive
Skip Navigation Links.
Expand 20242024
Expand 20232023
Expand 20222022
Expand 20212021
Expand 20202020
Expand 20192019
Expand 20182018
Expand 20172017
Expand 20162016
Expand 20152015
Expand 20142014
Expand 20132013
Expand 20122012
Expand 20112011
Expand 20102010

Search by Topic
Skip Navigation Links.

 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
Follow First Trust:  
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2024 All rights reserved.